Yuan Zhang | Pharmaceutical Sciences | Best Researcher Award

Prof. Yuan Zhang | Pharmaceutical Sciences | Best Researcher Award

Deputy Director at South China University of Technology, China📖

Dr. Yuan Zhang is a distinguished professor at South China University of Technology, where he serves in the School of Biomedical Sciences and Engineering at the Guangzhou International Campus. Additionally, he contributes to the National Engineering Research Center for Tissue Restoration and Reconstruction. With a career marked by groundbreaking research in pharmaceutical sciences and nanotechnology, Dr. Zhang has established himself as a leading figure in drug delivery systems and cancer research.

Profile

Google Scholar Profile

Education Background🎓

Dr. Zhang completed his postdoctoral research fellowship at the Massachusetts Institute of Technology (MIT) from 2013 to 2016, under the mentorship of Prof. Darrell J. Irvine, a National Academy of Medicine member and Howard Hughes Medical Institute (HHMI) investigator. He earned his Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill in 2013, where he specialized in molecular pharmaceutics and nanotechnology. Before this, he received his M.S. in Pharmaceutical Sciences from Peking University in 2009, guided by Prof. Qiang Zhang, a member of the Chinese Academy of Engineering. Dr. Zhang also holds dual bachelor’s degrees in Pharmaceutical Sciences and Economics from Peking University.

Professional Experience🌱

Dr. Zhang began his academic career as an Assistant Professor at the University of Rhode Island from 2016 to 2019, where he excelled in advancing biomedical and pharmaceutical sciences. Since 2019, he has been a professor at South China University of Technology, contributing significantly to research in tissue restoration and reconstruction while mentoring the next generation of scientists.

Research Interests🔬

Dr. Zhang’s research focuses on nanotechnology for drug delivery, tissue engineering, and cancer therapy. He explores innovative approaches to enhance the efficacy and precision of drug delivery systems, emphasizing translational research to improve patient outcomes. His contributions to molecular pharmaceutics and tissue restoration have opened new avenues in biomedical sciences, particularly in regenerative medicine and targeted therapeutics.

Author Metrics

Dr. Zhang’s research has led to numerous high-impact publications in leading journals, reflecting his expertise in drug delivery systems, nanotechnology, and cancer therapeutics. His work is widely cited, underscoring his influence and thought leadership in pharmaceutical sciences.

Publications Top Notes 📄

1. In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles

Authors: Y. Zhang, A. Satterlee, L. Huang
Journal: Molecular Therapy, 2012, 20(7), pp. 1298–1304
Citations: 470
Summary:
This paper discusses the challenges of in vivo gene delivery using nonviral vectors, emphasizing strategies to overcome barriers such as stability, targeting efficiency, and cellular uptake. The study highlights advancements in nanotechnology and biomaterials that enhance the potential of nonviral vectors for clinical applications in gene therapy.

2. Delivering Safer Immunotherapies for Cancer

Authors: L. Milling, Y. Zhang, D.J. Irvine
Journal: Advanced Drug Delivery Reviews, 2017, 114, pp. 79–101
Citations: 305
Summary:
The paper reviews recent developments in cancer immunotherapies, focusing on minimizing systemic toxicity while enhancing efficacy. It explores strategies such as targeted delivery systems, immune checkpoint inhibitors, and nanocarriers to ensure safer and more effective immunotherapy solutions.

3. Nanoparticle Anchoring Targets Immune Agonists to Tumors Enabling Anti-Cancer Immunity Without Systemic Toxicity

Authors: Y. Zhang, N. Li, H. Suh, D.J. Irvine
Journal: Nature Communications, 2018, 9(1), Article 6
Citations: 215
Summary:
This study introduces a novel nanoparticle system for targeting immune agonists directly to tumors, thereby inducing a potent anti-cancer immune response. The method reduces systemic toxicity and enhances the therapeutic index of immune-based treatments, representing a breakthrough in cancer immunotherapy.

4. Biomimetic Diselenide‐Bridged Mesoporous Organosilica Nanoparticles as an X‐Ray‐Responsive Biodegradable Carrier for Chemo‐Immunotherapy

Authors: D. Shao, F. Zhang, F. Chen, X. Zheng, H. Hu, C. Yang, Z. Tu, Z. Wang, Y. Zhang, et al.
Journal: Advanced Materials, 2020, 32(50), Article 2004385
Citations: 199
Summary:
The paper presents innovative mesoporous organosilica nanoparticles with diselenide bridges for X-ray-triggered chemo-immunotherapy. These nanoparticles are biodegradable, providing a controlled drug release system that combines chemotherapy and immunotherapy for enhanced anti-cancer efficacy.

5. Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy

Authors: S. Guo, Y. Wang, L. Miao, Z. Xu, C.M. Lin, Y. Zhang, L. Huang
Journal: ACS Nano, 2013, 7(11), pp. 9896–9904
Citations: 145
Summary:
This research develops lipid-coated cisplatin nanoparticles that induce a “neighboring effect,” enhancing anticancer efficacy. The study demonstrates the nanoparticles’ ability to selectively target cancer cells, improve drug delivery, and minimize off-target toxicity, making them a promising candidate for advanced chemotherapy.

Conclusion

Dr. Yuan Zhang exemplifies the qualities of an outstanding researcher, with groundbreaking contributions to pharmaceutical sciences and nanotechnology. His work has significantly advanced the fields of drug delivery, cancer therapy, and tissue restoration, earning him high citation metrics and global recognition. By focusing more on translational research, interdisciplinary collaborations, and public engagement, Dr. Zhang could further amplify the real-world impact of his innovations.

Given his achievements, leadership roles, and potential for future contributions, Dr. Zhang is a highly suitable candidate for the Best Researcher Award, making him a deserving recipient of this prestigious honor.

Mazen Juratli- Medicine- Outstanding Scientist Award

Mazen Juratli- Medicine- Outstanding Scientist Award

Prof. Mazen Juratli distinguished academic and researcher in the field Medicine. He is a dedicated and accomplished Assistant Professor and Senior Consultant Surgeon with a strong background in General, Visceral, and Transplant Surgery, specializing in upper GI tumors, reflux surgery, and peritoneal carcinomatosis. His experience encompasses both the clinical and research facets of surgical oncology, demonstrating a steadfast dedication to advancing medical science and enhancing patient care. He is actively pursuing opportunities to make substantial contributions to the field of surgery and academic medicine, particularly in the realm of Upper GI and peritoneal carcinomatosis surgery, along with related areas.

🌐 Professional Profile

Educations📚📚📚

He earned his Ph.D. in Interdisciplinary Biomedical Science (IBS) from the Arkansas Nanomedicine Center at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, completing his studies between January 2012 and May 2014. Prior to that, he attended medical school at Philipps University in Marburg, Germany, from October 2003 to November 2009.

 Experience:

He is currently an Assistant Professor and Senior Consultant Surgeon at the University Hospital of Muenster in Muenster, Germany, within the Department of Generalhttps://networkscience-conferences.researchw.com/?p=33910&preview=true, Visceral, and Transplant Surgery. He specializes as an Upper Gastrointestinal (GI) Surgeon, adept in robotic, minimally invasive, and open surgeries. Additionally, he heads the Stomach Cancer and Peritoneal Carcinomatosis Surgical Center, serves as Deputy Head of the Esophagus Cancer Center, and leads the Surgical Biobank. He is also the Principal Investigator (PI) for the Liquid Biopsy Research Group. His licensure and certifications include being a Senior Explant Surgeon for Donor Surgery: Liver and Kidney (since October 2023) and a Certified Center Surgeon for the Upper GI Tract (since January 2023). He is a member of the Board of Directors of the Interdisciplinary Working Group for Clinical Hemotherapy (IAKH e.V.) and holds an additional qualification in Specialized Visceral Surgery (Zusatzbezeichnung Spezielle Viszeralchirurgie) from the Ärztekammer Westfalen-Lippe, Germany, since September 2022. He became a Fellow of the European Board of Surgery (F.E.B.S.) in Surgical Oncology in September 2022 and has been an Assistant Professor (Privatdozent Dr. med. habil.) since January 2021. He has served as a Senior Consultant Surgeon (Oberarzt) in the Department of General, Visceral, and Transplant Surgery at the University Hospital of Muenster since September 2020. He obtained his German Board Certification in Visceral Surgery – Consultant Surgeon (Facharzt) from the Ärztekammer Hessen, Germany, in June 2019. He earned his Ph.D. from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR, USA, in December 2014 and his Doctor of Medicine (Dr. med.) from Philipps University in Marburg, Germany, in December 2009, where he also obtained his German Federal License (Approbation) in November 2009.

Awards, Grants and Honors

He has received numerous awards, grants, and honors throughout his career. In 2024, he secured industrial grant funding from Johnson & Johnson for a project on surgical smoke exposure investigation in surgical safety, amounting to €169,681, and also received the German Society for General and Visceral Surgery (DGAV) Travel Award, valued at €5000. He earned abstract prizes for his pilot studies on diagnostic and prognostic tumor markers in adenocarcinomas of the gastroesophageal junction and extracellular vesicles as potential biomarkers for hepatocellular carcinoma, presented at Visceral Medicine 2023 in Hamburg and NRW-Visceral Medicine 2023 in Essen, each prize valued at €500. In 2022, he won another abstract prize for his work on the long-term effects of liver resection on circulating stem cells in hepatocellular carcinoma, presented at Visceral Medicine in Hamburg. He was recognized as a Medical Scientist by the Else Kröner-Forschungskolleg (EKFK) in 2018 and received a grant of €15,000 from the B. Braun-Stiftung the same year. In 2017, he was awarded €66,000 for young talent promotion by Frankfurt Research Promotion at Goethe University, Frankfurt am Main, Germany. His achievements also include the Frankfurt Research Prize of the Rudolf Geißendörfer Foundation in 2015, valued at €5,000, and a poster prize at the 19 Chirurgische Forschungstage in Würzburg, Germany, in 2015, valued at €500. He received the second prize for the Cancers Best Paper Award in 2015 and the German Academic International Network (GAIN) Travel Award to attend the 18th European Career Fair (ECF) in Boston, MA, USA, in 2014, valued at €2,000. He was honored with the People’s Choice award for Science as Art at the Nanotechnology for Health Care Conference in Petit Jean, AR, USA, in 2014. Additionally, he was granted $78,000 by the Arkansas Breast Cancer Research Program (ABCRP) in 2013 and received €50,000 from the DFG – German Research Foundation in 2012.

 

📝🔬Publications📝🔬

  • Jens Hoelzen, Lukas Fortmann, Dhruvajyoti Roy, Carsten Szardenings, Martina Holstein, Ann-Kathrin Eichelmann,Emile Rijcken,Brooke E. Frankauer, Peter Barth, Eva Wardelmann, Andreas Pascher, and Mazen A. Juratli. Robotic-Assisted Esophagectomy with Total Mesoesophageal Excision EnhancesR0-Resection in Patients with Esophageal Cancer – a single-center experience. Surgery 05/2024. In Press
  • Lamberty SA, Hoelzen JP, Katou S, Becker F, Juratli MA, Andreou A, Morgül MH, Pascher A, Strücker B. Validation of the IWATE Criteria in Robotic-Assisted Liver Resections. J Clin Med. 2024 May 3;13(9):2697. doi: 10.3390/jcm13092697. PMID: 38731226; PMCID: PMC11084793.
  • Juratli, M.A., Pollmann, N.S., Oppermann, E. et al. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma. Sci Rep 14, 5322 (2024). https://doi.org/10.1038/s41598-024-55888-8.
  • Diedrich AM, Daneshgar A, Tang P, Klein O, Mohr A, Onwuegbuchulam OA, von Rueden S, Menck K, Bleckmann A, Juratli MA, Becker F, Sauer IM, Hillebrandt KH, Pascher A, Struecker B. Proteomic analysis of decellularized mice liver and kidney extracellular matrices. J Biol Eng. 2024 Feb 22;18(1):17. doi: 10.1186/s13036-024-00413-8. PMID: 38389090; PMCID: PMC10885605
  • de Jongh C, Cianchi F, Kinoshita T, Kingma F, Piccoli M, Dubecz A, Kouwenhoven E, van Det M, Mala T, Coratti A, Ubiali P, Turner P, Kish P, Borghi F, Immanuel A, Nilsson M, Rouvelas I, Hӧlzen JP, Rouanet P, Saint-Marc O, Dussart D, Patriti A, Bazzocchi F, van Etten B, Haveman JW, DePrizio M, Sabino F, Viola M, Berlth F, Grimminger PP, Roviello F, van Hillegersberg R, Ruurda J; UGIRA Collaborative Group. Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG): Results From the Prospective Multicenter International Ugira Gastric Registry. Ann Surg. 2023 Nov 3. doi: 10.1097/SLA.0000000000006147. Epub ahead of print. PMID: 37922237.
  • Hoelzen JP, Frankauer BE, Szardenings C, Roy D, Pollmann L, Fortmann L, Merten J, Rijcken E, Juratli MA, Pascher A. Reducing the Risks of Esophagectomies: A Retrospective Comparison of Hybrid versus Full-Robotic-Assisted Minimally Invasive Esophagectomy (RAMIE) Approaches. J Clin Med. 2023 Sep 7;12(18):5823. doi: 10.3390/jcm12185823. PMID: 37762765; PMCID: PMC10531670.Two senior authors
  • Peters AK, Juratli MA, Roy D, Merten J, Fortmann L, Pascher A, Hoelzen JP. Factors Influencing Postoperative Complications Following Minimally Invasive Ivor Lewis Esophagectomy: A Retrospective Cohort Study. J Clin Med. 2023 Aug 31;12(17):5688. doi: 10.3390/jcm12175688. PMID: 37685756; PMCID: PMC10488704.Contributed equally to the study
  • Mohr A, Besser M, Broichhausen S, Winter M, Bungert AD, Strücker B, Juratli MA,Pascher A, Becker F. The Influence of Apremilast-Induced Macrophage Polarization on Intestinal Wound Healing. J Clin Med. 2023 May 9;12(10):3359. doi: 10.3390/jcm12103359. PMID: 37240465; PMCID: PMC10219563

Pragati Tripathi – Biomedical Engineering – Best Researcher Award

Ms. Pragati Tripathi distinguished academic and researcher in the field Biomedical Engineering.  She has held multiple academic positions since 2018, beginning as an Assistant Professor in the Department of Electronics and Communication Engineering at Vision Institute of Technology, Kanpur. She then transitioned to roles such as Research Associate at Sharda University, Greater Noida, and subsequently as an Assistant Professor in the same field at I.T.S Greater Noida. Currently, she serves as an Assistant Professor and Chief of Operations and Experiments (C.O.E.) in the ECE Department at I.T.S Greater Noida, where she also played a pivotal role in establishing an IoT lab. Her contributions extend beyond teaching, as evidenced by her involvement in hosting e-Yantra programs and workshops, including one conducted in collaboration with IIT Bombay. Furthermore, she has coordinated mini-projects for second and third-year students, managed data for R&D consultancy, and contributed to the improvement of departmental logistics and student performance. Her proactive approach is reflected in her creation and implementation of activities aimed at enhancing student careers and her active participation in departmental and college initiatives, where she has supported various functional activities and committees.

 

🌐 Professional Profiles

Educations📚📚📚

She is currently pursuing a Ph.D. in Artificial Intelligence & Machine Learning at Gautam Buddha University, Greater Noida, a journey she embarked on in 2019. Prior to this, she completed her MTech in Power Electronics & Drives from the same institution in 2018. Her educational journey began with a Master’s in Electronics from C.S.J.M. University, Kanpur, in 2016, following which she obtained a Bachelor’s degree from the same university in 2014. She completed her Intermediate education at Virendra Swarup 21st Century, Kanpur, in 2011, and her High School education at Vikram Khanna High School, Kanpur, in 2009. Through her academic pursuits, she has demonstrated a commitment to expanding her knowledge and expertise in the field of electronics and related disciplines.

 

INTERNATIONAL CONFERENCES 🎟️

She has made significant contributions to the field of engineering and technology, as evidenced by her numerous publications and presentations at international conferences. Her research interests span across various domains, including artificial intelligence, smart communication, medical imaging, and renewable energy systems. Notable works include her studies on signal processing techniques for medical applications, such as denoising electrocardiogram signals and analyzing brain tumor detection through MRI. Additionally, she has explored topics in energy efficiency, such as modeling hybrid PV-diesel-battery systems and analyzing the stability of VSC-HVDC transmission systems. Her research endeavors also extend to innovative technologies like IoT-based weather monitoring systems and the mathematical modeling of graphene. Through her scholarly pursuits, she has demonstrated a commitment to advancing knowledge and innovation in engineering, contributing to the scientific community’s understanding and application of emerging technologies.

 

Honors & Awards 🏆🏆🥇

She has garnered numerous awards and achievements throughout her academic and extracurricular endeavors. Notable among these are her participation in events like Abhivyanjana in 2016 and 2017, where she served as a co-coordinator. Additionally, she demonstrated her leadership skills as a co-coordinator at the NanofiM International Conference in 2017 and various IEEE events. Her active involvement in IEEE activities earned her recognition, including the Outstanding Volunteer Award in the IEEE GBU Branch and the Outstanding Social Media Coordinator Award in the IEEE Delhi Region. Furthermore, she has contributed to sports events such as football and badminton, achieving commendable results like runner-up and securing the 2nd position. Her versatile engagement extends to English Group Discussions and football tournaments, showcasing her diverse interests and contributions to both academic and extracurricular spheres.

 

POSITION &RESPONSIBILITY

She has actively contributed to various projects and events, showcasing her organizational skills and leadership capabilities. As a Supervisor, she led a major project on IoT-based Agricultural monitoring systems at the Department of ECE, I.T.S. Engineering College during the 2023-24 session. Her role extended to being the Organizing Secretary for the Inter-College Tech-Vision Project Exhibition Competition at I.T.S Greater Noida in 2023, where she ensured the smooth execution of the event. Furthermore, she served as an Organizer for Nano fiM, an international conference held at Gautam Buddha University in 2017, and as a Coordinator for the International Conference (ELECRAMA2018) at Auto Expo, Greater Noida. Her dedication to extracurricular activities is evident through her volunteer work as a student coordinator in the Art Club at Gautam Buddha University from 2016 to 2018. Additionally, she took on the responsibility of organizing cultural events like the Cultural Fest, AbhiyanJana, at Gautam Buddha University in 2017, demonstrating her commitment to enhancing the campus experience for her peers.

 

Publications📚📚

Panagiotis Karanis – Biomedical Research – Best Researcher Award

Panagiotis Karanis – Biomedical Research

Dr. Panagiotis karanis  distinguished academic and researcher in the field Biomedical research, infectious diseases, climate changes.  Professor Karanis is a resourceful and dedicated professor with an impressive academic background,
excellent publication record and significant teaching experiences in the fields of Emerging Infectious
Parasitic and Tropical Diseases and Human Anatomy. Possesses excellent interpersonal and liaison skills
with the ability to build and maintain positive working relationships. Possesses mature administrative and
managerial skills and solid experience in science policy and public health. Enjoys worldwide collaborating
in a productive and successful team and thrives in challenging environments. He was 1000 Talent Plan
Expert (2014-2017) in Qinghai, China.

🌐 Professional Profiles

Educations: 📚🎓

Professor Dr. Panagiotis Karanis has held various esteemed positions in the field of anatomy and biomedicine, showcasing an extensive and distinguished career spanning several decades. From 2019 to the present, he serves as a Professor of Anatomy and the Coordinator of the Unit of Anatomy & Morphology at the Medical School, University of Nicosia, Nicosia, Cyprus. His contributions extend globally, as he has been an international advisor, consultant, and visiting professor at numerous universities.

During the period from 2014 to 2018, Professor Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at the State Key Laboratory for Plateau Ecology and Agriculture at Qinghai University in Xining, China. His expertise was recognized internationally, as he was selected as a Foreign Expert in the 1000 Talent Plan, Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese experts in China.

Earlier in his career, from 2009 to the present, Professor Karanis made significant contributions as a Professor of Anatomy at the Medical School, University of Cologne, Germany. Prior to this, he served as an Associate Professor and later as a Full Professor at the National Research Centre for Protozoan Diseases (NRCPD) in Japan from 2006 to 2007.

The trajectory of Professor Karanis’s career is marked by academic achievements. In 1999, he received Venia legendi in Parasitology (PD Dr.) and completed his Habilitation in Clinical-Theoretical Medicine at the Medical Faculty, University of Bonn, Germany. His academic journey began with a PhD in Parasitology, focusing on ‘UV-Disinfection of Protozoan Parasites’ at the University of Bonn in 1992. Earlier, in 1987, he earned a Diploma in Biology from the University of Bochum, Germany.

Professor Karanis’s educational background is diverse, including studies in Biology at the Universities of Bielefeld, Düsseldorf, and Bochum from 1980 to 1986. He also pursued complementary studies of Medicine at the Universities of Bochum and Cologne, completing the pre-clinical medical curriculum. His commitment to academia and research has made him a respected figure in the international scientific community, contributing significantly to the fields of anatomy, biomedicine, and parasitology.

Research Interests: 🧬🔬

Biomedical research, infectious diseases, climate changes,Applications of Network Science and Graph Analytics in Social, Biological, and Technological Networks

Awards and Achievements: 🏆👏

  •  Prof. Karanis is included on the annual list of 100,000 top scientists worldwide and, correspondingly, in
    the top 2 per cent of scientists in their field, according to a team of researchers at Stanford University in
    the USA. The updated 2020 list is based on a range of citation metrics that provides standardized data
    across those fields and subfields, in arriving at the (2019) single year impact result of more than 8,000,000
    scientists worldwide.
  • Gained worldwide administrative and managerial skills and experiences in science policy and public
    health. Successfully established 5 Laboratories / Institutions in Bonn / Germany (Waterborne and Vectorborne
    Parasitic Diseases), Thessaloniki / Greece (Leishmania and Sandflies), Cologne / Germany (Medical and
    Molecular Parasitology), Obihiro / Japan (Unit for Diseases Control and Genetics), Xining / China (Centre
    of Biomedicine and Infectious Diseases; the laboratory was promoted from the Chinese Government toState Key Laboratory of the Qinghai Province in China, 2016). The laboratories in Germany, Japan and
    China achieved an international reputation
  • Developed worldwide effective cooperations between many countries, in particular betweenEuropean
    and Asian countries
  •  Consultant at Qatar National Research Foundation and Qatar University, Doha, Qatar
  • Academic program review for the Master of Science in Biomedical Science, College of Health
    Sciences at Qatar University, Doha, Qatar, September 2018
  • Consultant” at Walailak University, Nakhon Si Thammarat, Thailand
  • Nominated as “Advisory Board Member” of the “Centre of Excellence for Medical Research and
    Innovative Products (CEMRIP)” in Thailand.
  • Nominated “National Distinguished Expert” and “State Specially Recruited Expert” of China
  • Selected in 1000 Talent Plan, the Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese
    experts, China, 2014, leading into ongoing innovative and promising collaborations with China
  • Invitation for Short Term – Fellowship – Program for Malaria Research in Japan by JSPS (Japanese
    Society of Promotion of Science), 12th January – 11th March 2014

Career Summary 

Dr. Panagiotis Karanis is a distinguished parasitologist with a wealth of expertise and a prolific career spanning several prestigious institutions across the globe. Serving as a Guest Professor at the University of Padova in Italy during 2019 and 2020, as well as a Consultant at the College of Public Health in Qatar in 2018, he contributed significantly to the field of parasitology. Dr. Karanis has been a Consultant at Walailak University in Thailand since 2017, where he has provided guidance and international supervision for PhD students.

His academic endeavors include roles as an Invited Professor at the University of Alexandroupolis and the University of Ioannina in Greece, where he delivered lectures on infectious diseases to both undergraduate and postgraduate students. Notably, from 2014 to 2018, Dr. Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at Qinghai University in China.

As a Foreign Expert in the 1000 Talent Plan Recruitment Program, he played a pivotal role in elevating the laboratory to the State Key Laboratory for Plateau Ecology and Agriculture of the Qinghai Province. Dr. Karanis’s contributions extended to advising the Chinese government on research ideas, particularly in waterborne and vectorborne diseases, and his efforts in developing Cryptosporidium culture assays for drug testing garnered recognition and funding from prestigious institutions such as the Bill and Melinda Gates Foundation. His comprehensive involvement in academia, research, and international collaborations underscores his commitment to advancing the field of parasitology and infectious diseases.

 

📚Top Noted Publication